BioCentury
ARTICLE | Financial News

NGM Biopharmaceuticals completes venture financing

July 22, 2013 7:00 AM UTC

NGM Biopharmaceuticals Inc., South San Francisco, Calif. Business: Endocrine/Metabolic, Cardiovascular Date completed: 7/18/13 Type: Venture financing Raised: $50 million Investors: Topspin Fund; The ...